Safety and tolerability of delayed-release dimethyl fumarate administered as add on therapy to beta interferons or glatiramer acetate in relapsing-remitting multiple sclerosis (RRMS) patients

Authors
Category Primary study
JournalNeurology
Year 2014
This article has no abstract
Epistemonikos ID: 61d97e10121e25ef346a907bbd12d8b1671d448c
First added on: Feb 06, 2025